IIMA, Novo Nordisk India sign pact to tackle obesity using multi-pronged collab
The Memorandum of Understanding (MoU) signed for five years, till 2030, aims 'to strengthen the healthcare ecosystem through a multi- dimensional approach focused on non-communicable diseases (NCDs), especially obesity,' according to a statement.
'As a part of this MoU, NNIPL and IIMA will co-develop and implement impactful programmes under three key pillars: Health System Capacity Building, Policy Advocacy, and Health Economics. The partnership will prioritise creation of educational content, development of model frameworks for obesity clinics, and data-driven policy formulation to address the burden of obesity in India,' according to the statement.
'It will also assist in conducting research to assess its economic impact on individuals, workforce productivity, healthcare system, and the overall economy,' a statement issued by IIMA on Wednesday stated.
Prof Bharat Bhasker, Director, IIM Ahmedabad stated, 'This collaboration with Novo Nordisk India brings together healthcare and public policy — two domains where data and research can enable lasting change. At IIMA, we aim to apply our academic rigour to generate actionable insights for policymakers, healthcare professionals, and communities tackling non-communicable diseases like obesity.'
The MoU also outlines detailed research initiatives, including paper publications with government institutions and pilot outreach programmes.
Novo Nordisk India Pvt Ltd Managing Director Vikrant Shrotriya in the statement said, 'India's healthcare systems must evolve to address the growing challenge of non-communicable diseases, particularly obesity. This collaboration with IIM Ahmedabad will jointly shape interventions that are research-backed, scalable, and sustainable.'
Chhavi Moodgal, CEO, IIMA Endowment Fund, added, 'Strategic partnerships like this reflect IIMA's commitment to addressing complex public health challenges through rigorous research, data-led solutions, and collaborative action.'
The IIMA Endowment Fund (IIMAEF), the Institute's unified fundraising and philanthropic arm for all donations from alumni, as well as corporate and CSR partners, played a facilitative role in shaping this partnership.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
10-07-2025
- India Today
IIM Ahmedabad and Novo Nordisk India partner to combat obesity and enhance healthcare systems
Novo Nordisk's weight loss medication, Wegovy, has also made its debut in India, marking a significant milestone in the country's battle against obesity. On July 8, 2025, the Indian Institute of Management Ahmedabad (IIMA) and Novo Nordisk India Pvt Ltd (NNIPL) entered into a strategic collaboration aimed at enhancing the healthcare ecosystem in India. The five-year partnership will focus primarily on addressing non-communicable diseases (NCDs), with a particular emphasis on combating obesity. Novo Nordisk's weight loss medication, Wegovy, has also made its debut in India, marking a significant milestone in the country's battle against obesity. The MoU sets out a broad framework for joint action in three key areas: strengthening healthcare systems, advocating for policy changes, and advancing health economics. This includes co-developing models for obesity clinics, producing educational resources for healthcare professionals, and designing data-driven public health policies. The partnership will also encompass research initiatives that evaluate the economic consequences of obesity on personal health, workforce productivity, and the national healthcare system. These research activities aim to highlight the broader financial impact of obesity on society and help inform future policy decisions. In addition to research, the collaboration will involve publishing joint papers in association with government agencies, rolling out pilot outreach initiatives, and exploring the potential of telemedicine in managing NCDs, particularly in rural and underserved regions. The aim is to generate valuable insights that can both shape healthcare policies and improve service delivery across the country. The IIMA Endowment Fund (IIMAEF), which supports strategic partnerships and philanthropic endeavours, played a pivotal role in facilitating this collaboration. Through the fund, IIMA is able to leverage its academic resources to address critical societal issues such as public health. This partnership is designed to integrate educational, corporate, and research capabilities to create scalable healthcare models for managing NCDs, with a central focus on obesity. It is expected to bring long-term improvements in both health outcomes and policy frameworks across India.
Indian Express
10-07-2025
- Indian Express
IIMA, Novo Nordisk India sign pact to tackle obesity using multi-pronged collab
A pact was signed to tackle obesity through a long-term multi-pronged collaboration between the Indian Institute of Management Ahmedabad (IIMA) and healthcare company Novo Nordisk India Pvt Ltd (NNIPL) on Tuesday. The Memorandum of Understanding (MoU) signed for five years, till 2030, aims 'to strengthen the healthcare ecosystem through a multi- dimensional approach focused on non-communicable diseases (NCDs), especially obesity,' according to a statement. 'As a part of this MoU, NNIPL and IIMA will co-develop and implement impactful programmes under three key pillars: Health System Capacity Building, Policy Advocacy, and Health Economics. The partnership will prioritise creation of educational content, development of model frameworks for obesity clinics, and data-driven policy formulation to address the burden of obesity in India,' according to the statement. 'It will also assist in conducting research to assess its economic impact on individuals, workforce productivity, healthcare system, and the overall economy,' a statement issued by IIMA on Wednesday stated. Prof Bharat Bhasker, Director, IIM Ahmedabad stated, 'This collaboration with Novo Nordisk India brings together healthcare and public policy — two domains where data and research can enable lasting change. At IIMA, we aim to apply our academic rigour to generate actionable insights for policymakers, healthcare professionals, and communities tackling non-communicable diseases like obesity.' The MoU also outlines detailed research initiatives, including paper publications with government institutions and pilot outreach programmes. Novo Nordisk India Pvt Ltd Managing Director Vikrant Shrotriya in the statement said, 'India's healthcare systems must evolve to address the growing challenge of non-communicable diseases, particularly obesity. This collaboration with IIM Ahmedabad will jointly shape interventions that are research-backed, scalable, and sustainable.' Chhavi Moodgal, CEO, IIMA Endowment Fund, added, 'Strategic partnerships like this reflect IIMA's commitment to addressing complex public health challenges through rigorous research, data-led solutions, and collaborative action.' The IIMA Endowment Fund (IIMAEF), the Institute's unified fundraising and philanthropic arm for all donations from alumni, as well as corporate and CSR partners, played a facilitative role in shaping this partnership.
Time of India
09-07-2025
- Time of India
IIM Ahmedabad, Novo Nordisk India partner to strengthen obesity care ecosystem
The Indian Institute of Management Ahmedabad on Wednesday said it has signed an agreement with Novo Nordisk India to strengthen the obesity care ecosystem in the country for five years till 2030. The memorandum of understanding, inked on Tuesday, aims to strengthen the healthcare ecosystem in India through a multi-dimensional approach focused on non-communicable diseases (NCDs), especially obesity, the Indian Institute of Management Ahmedabad (IIMA) said in a statement. "This collaboration with Novo Nordisk India brings together healthcare and public policy, two domains where data and research can enable lasting change. At IIMA, we aim to apply our academic rigour to generate actionable insights for policymakers, healthcare professionals, and communities tackling non-communicable diseases like obesity," IIM Ahmedabad Director Professor Bharat Bhasker said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo As a part of this collaboration, Novo Nordisk India (NNIPL) and IIMA will co-develop and implement impactful programmes under three key pillars - Health System Capacity Building, Policy Advocacy , and Health Economics. Novo Nordisk Managing Director India Vikrant Shrotriya said, "This collaboration with IIM Ahmedabad will jointly shape interventions that are research-backed, scalable, and sustainable. It is our firm belief that partnerships like these can bring lasting change and help improve health outcomes for millions".
